$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 15 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.82 | 100 | 782 | 3,109,606 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.81 | 400 | 3,124 | 3,109,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.78 | 300 | 2,334 | 3,110,106 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.77 | 300 | 2,331 | 3,110,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.73 | 200 | 1,546 | 3,110,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.72 | 200 | 1,544 | 3,110,906 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.71 | 900 | 6,939 | 3,111,106 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.66 | 200 | 1,532 | 3,112,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.65 | 200 | 1,530 | 3,112,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.63 | 700 | 5,341 | 3,112,406 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.62 | 600 | 4,572 | 3,113,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.61 | 400 | 3,044 | 3,113,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.60 | 600 | 4,560 | 3,114,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.59 | 800 | 6,072 | 3,114,706 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.58 | 900 | 6,822 | 3,115,506 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.57 | 1,600 | 12,112 | 3,116,406 | 3.1 M to 3.1 M (-0.05 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.56 | 166 | 1,255 | 3,118,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.55 | 300 | 2,265 | 3,118,172 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.54 | 834 | 6,288 | 3,118,472 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.51 | 300 | 2,253 | 3,119,306 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.56 | 603 | 4,559 | 3,119,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 10,603 | 4,559 | 3,120,209 | 3.1 M to 3.1 M (+0.34 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.07 | 500 | 4,035 | 3,109,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.06 | 300 | 2,418 | 3,110,106 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.02 | 800 | 6,416 | 3,110,406 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.01 | 300 | 2,403 | 3,111,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 12,374 | 5,321 | 760,240 | |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.00 | 500 | 4,000 | 3,111,506 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.99 | 200 | 1,598 | 3,112,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.98 | 400 | 3,192 | 3,112,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.97 | 500 | 3,985 | 3,112,606 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.96 | 600 | 4,776 | 3,113,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.94 | 600 | 4,764 | 3,113,706 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.93 | 900 | 7,137 | 3,114,306 | 3.1 M to 3.1 M (-0.03 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.92 | 100 | 792 | 3,115,206 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.91 | 100 | 791 | 3,115,306 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.90 | 400 | 3,160 | 3,115,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.88 | 300 | 2,364 | 3,115,806 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.87 | 600 | 4,722 | 3,116,106 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.86 | 200 | 1,572 | 3,116,706 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.84 | 500 | 3,920 | 3,116,906 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.82 | 400 | 3,128 | 3,117,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.80 | 400 | 3,120 | 3,117,806 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.79 | 200 | 1,558 | 3,118,206 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.76 | 200 | 1,552 | 3,118,406 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.75 | 300 | 2,325 | 3,118,606 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.72 | 300 | 2,316 | 3,118,906 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.71 | 100 | 771 | 3,119,206 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.69 | 300 | 2,307 | 3,119,306 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.68 | 87 | 668 | 3,119,606 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.65 | 200 | 1,530 | 3,119,693 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.63 | 400 | 3,052 | 3,119,893 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.62 | 613 | 4,671 | 3,120,293 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.61 | 100 | 761 | 3,120,906 | 3.1 M to 3.1 M (0.00 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.57 | 300 | 2,271 | 3,121,006 | 3.1 M to 3.1 M (-0.01 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.87 | 674 | 5,304 | 3,121,306 | 3.1 M to 3.1 M (-0.02 %) |
| Nov 21 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 12,374 | 5,321 | 3,121,980 | 3.1 M to 3.1 M (+0.40 %) |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Hooper Matthew | Vice Pres & General ... | Option Exercise | A | 7.68 | 125,000 | 960,000 | 125,000 | |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 42,340 | 18,206 | 772,614 | |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 7.78 | 2,340 | 18,205 | 3,109,606 | 3.1 M to 3.1 M (-0.08 %) |
| Nov 13 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 42,340 | 18,206 | 3,111,946 | 3.1 M to 3.1 M (+1.38 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,202,313 | |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.16 | 100 | 916 | 700,000 | 700.1 K to 700 K (-0.01 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.15 | 300 | 2,745 | 700,100 | 700.4 K to 700.1 K (-0.04 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.07 | 300 | 2,721 | 700,400 | 700.7 K to 700.4 K (-0.04 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.06 | 1,090 | 9,875 | 700,700 | 701.8 K to 700.7 K (-0.16 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.05 | 710 | 6,426 | 701,790 | 702.5 K to 701.8 K (-0.10 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.04 | 4,700 | 42,488 | 702,500 | 707.2 K to 702.5 K (-0.66 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.03 | 12,700 | 114,681 | 707,200 | 719.9 K to 707.2 K (-1.76 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.02 | 4,700 | 42,394 | 719,900 | 724.6 K to 719.9 K (-0.65 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 9.01 | 400 | 3,604 | 724,600 | 725 K to 724.6 K (-0.06 %) |
| Nov 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 725,000 | 700 K to 725 K (+3.57 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,754 | 6,774 | 814,954 | |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.20 | 275 | 2,530 | 3,069,606 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.18 | 400 | 3,672 | 3,069,881 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.17 | 200 | 1,834 | 3,070,281 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.16 | 25 | 229 | 3,070,481 | 3.1 M to 3.1 M (0.00 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.15 | 800 | 7,320 | 3,070,506 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.14 | 800 | 7,312 | 3,071,306 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.13 | 400 | 3,652 | 3,072,106 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 100 | 912 | 3,072,506 | 3.1 M to 3.1 M (0.00 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 300 | 2,733 | 3,072,606 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 600 | 5,454 | 3,072,906 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.08 | 600 | 5,448 | 3,073,506 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.07 | 100 | 907 | 3,074,106 | 3.1 M to 3.1 M (0.00 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.06 | 200 | 1,812 | 3,074,206 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.05 | 400 | 3,620 | 3,074,406 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 900 | 8,136 | 3,074,806 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.03 | 200 | 1,806 | 3,075,706 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 1,100 | 9,922 | 3,075,906 | 3.1 M to 3.1 M (-0.04 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 200 | 1,802 | 3,077,006 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 46 | 414 | 3,077,206 | 3.1 M to 3.1 M (0.00 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 600 | 5,394 | 3,077,252 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 1,354 | 12,159 | 3,077,852 | 3.1 M to 3.1 M (-0.04 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 700 | 6,279 | 3,079,206 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 700 | 6,272 | 3,079,906 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 1,900 | 17,005 | 3,080,606 | 3.1 M to 3.1 M (-0.06 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.94 | 1,100 | 9,834 | 3,082,506 | 3.1 M to 3.1 M (-0.04 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 300 | 2,679 | 3,083,606 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 300 | 2,676 | 3,083,906 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 400 | 3,564 | 3,084,206 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.98 | 754 | 6,771 | 3,084,606 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,754 | 6,774 | 3,085,360 | 3.1 M to 3.1 M (+0.51 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,747 | 6,771 | 830,708 | |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.12 | 200 | 1,824 | 3,069,606 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.11 | 500 | 4,555 | 3,069,806 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.10 | 400 | 3,640 | 3,070,306 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.09 | 500 | 4,545 | 3,070,706 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.04 | 600 | 5,424 | 3,071,206 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.02 | 1,500 | 13,530 | 3,071,806 | 3.1 M to 3.1 M (-0.05 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.01 | 400 | 3,604 | 3,073,306 | 3.1 M to 3.1 M (-0.01 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 9.00 | 900 | 8,100 | 3,073,706 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.99 | 760 | 6,832 | 3,074,606 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.98 | 500 | 4,490 | 3,075,366 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.97 | 1,600 | 14,352 | 3,075,866 | 3.1 M to 3.1 M (-0.05 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.96 | 3,040 | 27,238 | 3,077,466 | 3.1 M to 3.1 M (-0.10 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.95 | 1,500 | 13,425 | 3,080,506 | 3.1 M to 3.1 M (-0.05 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.94 | 556 | 4,971 | 3,082,006 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.93 | 500 | 4,465 | 3,082,562 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.92 | 854 | 7,618 | 3,083,062 | 3.1 M to 3.1 M (-0.03 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.91 | 690 | 6,148 | 3,083,916 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 9.06 | 747 | 6,768 | 3,084,606 | 3.1 M to 3.1 M (-0.02 %) |
| Oct 26 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,747 | 6,771 | 3,085,353 | 3.1 M to 3.1 M (+0.51 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.08 | 500 | 4,540 | 15,000 | 15.5 K to 15 K (-3.23 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.07 | 1,300 | 11,791 | 15,500 | 16.8 K to 15.5 K (-7.74 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.06 | 3,600 | 32,616 | 16,800 | 20.4 K to 16.8 K (-17.65 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.05 | 3,800 | 34,390 | 20,400 | 24.2 K to 20.4 K (-15.70 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.04 | 2,500 | 22,600 | 24,200 | 26.7 K to 24.2 K (-9.36 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.03 | 900 | 8,127 | 26,700 | 27.6 K to 26.7 K (-3.26 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.02 | 1,200 | 10,824 | 27,600 | 28.8 K to 27.6 K (-4.17 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.01 | 200 | 1,802 | 28,800 | 29 K to 28.8 K (-0.69 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.00 | 200 | 1,800 | 29,000 | 29.2 K to 29 K (-0.68 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.94 | 100 | 894 | 29,200 | 29.3 K to 29.2 K (-0.34 %) |
| Oct 18 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.92 | 700 | 6,244 | 29,300 | 30 K to 29.3 K (-2.33 %) |
| Oct 16 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.45 | 26,690 | 12,000 | 2,227,313 | |
| Oct 16 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.45 | 26,690 | 12,000 | 700,000 | 673.3 K to 700 K (+3.96 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.78 | 400 | 3,512 | 30,000 | 30.4 K to 30 K (-1.32 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.77 | 400 | 3,508 | 30,400 | 30.8 K to 30.4 K (-1.30 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.76 | 300 | 2,628 | 30,800 | 31.1 K to 30.8 K (-0.96 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.74 | 800 | 6,992 | 31,100 | 31.9 K to 31.1 K (-2.51 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.73 | 400 | 3,492 | 31,900 | 32.3 K to 31.9 K (-1.24 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.72 | 1,300 | 11,336 | 32,300 | 33.6 K to 32.3 K (-3.87 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.71 | 1,200 | 10,452 | 33,600 | 34.8 K to 33.6 K (-3.45 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.70 | 2,200 | 19,140 | 34,800 | 37 K to 34.8 K (-5.95 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.69 | 400 | 3,476 | 37,000 | 37.4 K to 37 K (-1.07 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.68 | 1,300 | 11,284 | 37,400 | 38.7 K to 37.4 K (-3.36 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.67 | 1,000 | 8,670 | 38,700 | 39.7 K to 38.7 K (-2.52 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.66 | 1,400 | 12,124 | 39,700 | 41.1 K to 39.7 K (-3.41 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.65 | 1,100 | 9,515 | 41,100 | 42.2 K to 41.1 K (-2.61 %) |
| Oct 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.64 | 1,700 | 14,688 | 42,200 | 43.9 K to 42.2 K (-3.87 %) |